Fred C Tenover
Overview
Explore the profile of Fred C Tenover including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
8094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang P, Wang Q, Zhou C, Zhang F, Gao X, Tenover F, et al.
J Clin Microbiol
. 2022 Nov;
60(12):e0118122.
PMID: 36374075
Rapid and accurate detection of carriers of carbapenemase-producing organisms (CPO) in hospitalized patients is critical for infection control and prevention. This study aimed to evaluate a pooling strategy for the...
12.
Tickler I, Gomez de la Torre J, Alvarado L, Obradovich A, Tenover F
J Glob Antimicrob Resist
. 2022 Sep;
31:135-140.
PMID: 36055547
Objectives: Pseudomonas aeruginosa is one of the leading causes of healthcare-associated infections globally. High-risk carbapenemase-encoding P. aeruginosa clones are disseminating in many regions. The aim of this study was to...
13.
Tenover F, Nicolau D, Gill C
Emerg Microbes Infect
. 2022 Mar;
11(1):811-814.
PMID: 35240944
Carbapenem-resistant (CR-PA) is a major healthcare-associated pathogen worldwide. In the United States, 10-30% of isolates are carbapenem-resistant, while globally the percentage varies considerably. A subset of carbapenem-resistant isolates harbour carbapenemases,...
14.
Tenover F, Tickler I
Antibiotics (Basel)
. 2022 Feb;
11(2).
PMID: 35203841
The application of molecular detection methods for bacterial pathogens has dramatically improved the outcomes of septic patients, including those with methicillin-resistant (MRSA) infections. Molecular methods can be applied to a...
15.
Han Y, Shi M, Jiang Q, Le W, Qin X, Xiong H, et al.
Front Cell Infect Microbiol
. 2022 Jan;
11:784610.
PMID: 35047416
Background: We aimed to evaluate the clinical performance of the GeneXpert (Xpert) CT/NG assay for the detection of (CT) and (NG) using urine and cervical swabs collected from patients in...
16.
Tenover F
Front Cell Infect Microbiol
. 2021 Oct;
11:715821.
PMID: 34650933
Infections caused by multidrug-resistant Gram-negative organisms have become a global threat. Such infections can be very difficult to treat, especially when they are caused by carbapenemase-producing organisms (CPO). Since infections...
17.
Gill C, Brink A, Chu C, Coetzee J, Dimopoulos G, Moodley C, et al.
Antimicrob Agents Chemother
. 2021 Jul;
65(10):e0127421.
PMID: 34310206
MICs and pharmacodynamics of ceftazidime and cefepime human-simulated regimens (HSR) against modified carbapenem inactivation method (mCIM)-positive Pseudomonas aeruginosa isolates harboring different OXA-10-like subtypes were described. The murine thigh model assessed...
18.
Tickler I, Shettima S, Dela Cruz C, Le V, Dewell S, Sumner J, et al.
Diagn Microbiol Infect Dis
. 2021 Jun;
101(1):115422.
PMID: 34111650
This study characterized the mechanisms of carbapenem resistance in gram-negative bacteria isolated from patients in Yola, Nigeria. Whole genome sequencing (WGS) was performed on 66 isolates previously identified phenotypically as...
19.
Liu Z, Bai L, Liu J, Lei J, Gao X, Tenover F, et al.
J Mol Diagn
. 2021 Jun;
23(8):1007-1014.
PMID: 34062286
The rapid detection and characterization of carbapenemases in isolates of Enterobacterales are crucial for precise antibiotic administration and infection control. This article reports the findings from a parallel evaluation of...
20.
Jin X, Zhang H, Wu S, Qin X, Jia P, Tenover F, et al.
J Mol Diagn
. 2020 Nov;
23(1):111-119.
PMID: 33212263
Rapid detection of carbapenemase-producing organisms is clinically desirable for hospital infection control and antibiotic stewardship. In this multicenter study, the Xpert Carba-R assay was evaluated for detection of the five...